Literature DB >> 27771464

Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.

Kui Wang1, Forrest M Kievit2, Miqin Zhang3.   

Abstract

Compared to conventional treatments, gene therapy offers a variety of advantages for cancer treatment including high potency and specificity, low off-target toxicity, and delivery of multiple genes that concurrently target cancer tumorigenesis, recurrence, and drug resistance. In the past decades, gene therapy has undergone remarkable progress, and is now poised to become a first line therapy for cancer. Among various gene delivery systems, nanoparticles have attracted much attention because of their desirable characteristics including low toxicity profiles, well-controlled and high gene delivery efficiency, and multi-functionalities. This review provides an overview on gene therapeutics and gene delivery technologies, and highlight recent advances, challenges and insights into the design and the utility of nanoparticles in gene therapy for cancer treatment.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer gene therapy; Gene delivery; Nanoparticles

Mesh:

Year:  2016        PMID: 27771464     DOI: 10.1016/j.phrs.2016.10.016

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  22 in total

Review 1.  Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.

Authors:  Tamkin Ahmadzada; Glen Reid; David R McKenzie
Journal:  Biophys Rev       Date:  2018-01-11

2.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system.

Authors:  Sharath Kumar Hari; Ankita Gauba; Neeraj Shrivastava; Ravi Mani Tripathi; Sudhir Kumar Jain; Akhilesh Kumar Pandey
Journal:  Drug Deliv Transl Res       Date:  2022-06-21       Impact factor: 4.617

4.  Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.

Authors:  Moein Farshchian; Mohammad Reza Abbaszadegan; Reihaneh Alsadat Mahmoudian; Fardin Fathi
Journal:  Mol Biotechnol       Date:  2022-04-26       Impact factor: 2.695

5.  Induction of Apoptosis and Inhibition of Invasion in Gastric Cancer Cells by Titanium Dioxide Nanoparticles.

Authors:  Reza Nasr; Hadi Hasanzadeh; Ali Khaleghian; Abdolvahab Moshtaghian; Alireza Emadi; Shima Moshfegh
Journal:  Oman Med J       Date:  2018-03

Review 6.  Streptococcal bacterial components in cancer therapy.

Authors:  Zeynab Marzhoseyni; Layla Shojaie; Seyed Alireza Tabatabaei; Ahmad Movahedpour; Mahmood Safari; Davoud Esmaeili; Maryam Mahjoubin-Tehran; Amin Jalili; Korosh Morshedi; Haroon Khan; Ranaa Okhravi; Michael R Hamblin; Hamed Mirzaei
Journal:  Cancer Gene Ther       Date:  2021-03-22       Impact factor: 5.987

7.  Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma.

Authors:  Setareh Sanati; Sahar Taghavi; Khalil Abnous; Seyed Mohammad Taghdisi; Maryam Babaei; Mohammad Ramezani; Mona Alibolandi
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 5.250

8.  Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.

Authors:  Guanyou Lin; Richard A Revia; Miqin Zhang
Journal:  Adv Funct Mater       Date:  2020-10-13       Impact factor: 18.808

Review 9.  Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses.

Authors:  Sakhawat Ali; Qin Xia; Tahir Muhammad; Liqun Liu; Xinyi Meng; David Bars-Cortina; Aamir Ali Khan; Yinghui Huang; Lei Dong
Journal:  Stem Cell Rev Rep       Date:  2021-07-28       Impact factor: 5.739

Review 10.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.